HURA — TuHURA Biosciences Balance Sheet
0.000.00%
- $159.21m
- $153.19m
Annual balance sheet for TuHURA Biosciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 10.5 | 11.8 | 1.53 | 4.91 | 3.62 |
| Net Total Receivables | — | — | — | — | 0.5 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 11.8 | 13.3 | 3.27 | 5.53 | 4.62 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.15 | 0.09 | 0.709 | 0.674 | 0.685 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 13.5 | 15.9 | 3.98 | 6.2 | 27.4 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 2.78 | 3.99 | 3.08 | 2.26 | 5.92 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 2.96 | 4.15 | 3.25 | 2.44 | 6.42 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 10.6 | 11.8 | 0.731 | 3.76 | 20.9 |
| Total Liabilities & Shareholders' Equity | 13.5 | 15.9 | 3.98 | 6.2 | 27.4 |
| Total Common Shares Outstanding | |||||
| Total Preferred Shares Outstanding |